Andrew D. Seidman, MD, is an attending physician at the Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, and professor of medicine, Weill Cornell Medical College, both in New York City. He has authored over 140 peer-reviewed publications, reviews and chapters, edited two textbooks, and served on the editorial boards of many journals, including the Journal of Clinical Oncology and Clinical Breast Cancer. His present research focuses on metastatic breast cancer.
Dr. Rosenbloom is an adjunct distinguished service professor emeritus of pediatrics at the University of Florida College of Medicine. He has served on numerous editorial boards and review committees for FDA, NIH and other grant agencies. He has also chaired the National Diabetes Commission task force that created the National Diabetes Data Group and authored/co-authored 375 articles and 80 chapters or books, on diabetes and growth.
Dr. Swee is professor of family medicine and community health, associate dean for faculty affairs and development and associate dean for education, all at Rutgers Robert Wood Johnson Medical School (RWJMS) in NJ. He was chairman of family medicine at RWJMS for 15 years and has written widely in the field of family medicine education. He's board certified in family medicine and continues to teach and see patients on a regular basis.
Dr. Rhee is an associate professor at Harvard Medical School and is also affiliated with the Massachusetts Eye & Ear Infirmary and Children's Hospital. Dr. Rhee is a clinician-scientist whose interests are in outcomes of new surgical technology, pediatric glaucomas and rare clinical syndromes. His laboratory research group is working to determine the underlying causes of glaucoma and better ways to treat it.
Dr. Whitehouse is division head emeritus in the division of endocrinology and metabolism at Henry Ford Hospital in Detroit. He is board certified in internal medicine and endocrinology and metabolism. His clinical interests include type 1 and type 2 diabetes, hypoglycemia, weight problems and other various endocrinological clinical entities.
Dr. Schimizzi is the cofounder of Carolina Arthritis Associates, PA, in Wilmington, NC, and has been a licensed and board certified rheumatologist in private practice for 30 years. He’s also affiliated with Coalition of State Rheumatology Associations. North Carolina Rheumatology Association, American College of Rheumatology, New Hanover-Pender Medical Society, American College of Physicians and National Association of Parliamentarians.
Dr. Hainsworth is the chief scientific officer at The Sarah Cannon Research Institute and a partner in Tennessee Oncology, PLLC, both in Nashville. He has been published extensively in the areas of unknown primary cancer, lung cancer and lymphoma.
Dr. Varga is director of the Northwestern Scleroderma Program and the John and Nancy Hughes Professor in the Division of Rheumatology at Northwestern University, Feinberg School of Medicine in Chicago. He is an internationally recognized expert in the diagnosis, treatment and study of fibrosis and scleroderma. Among numerous professional distinctions, he chairs the scientific and medical advisory board of the Scleroderma Foundation and the Basic Science Subcommittee of the American College of Rheumatology Planning Committee. He was also recognized as one of 50 “heroes” of the Arthritis Foundation and was the Scleroderma Foundation’s “doctor of the year” in 2006.
Dr. Hobbs is professor and chair of the Department of Family Medicine, distinguished chair and senior associate dean for Primary Care and Community Affairs in the Medical College of Georgia at Georgia Regents University. His specialty focuses on creating new undergraduate and graduate medical education teaching venues; maintaining educational competencies in distributed clinical teaching venues; acid-base, fluid and electrolyte disorders; and assessing the quality of chronic disease management in primary care environments.
Ms. Shockney is the administrative director of the Johns Hopkins Avon Foundation Breast Center and the Johns Hopkins Cancer Survivorship Program. She is responsible for the quality of care programs; patient education programs; the survivor volunteer team; community outreach at a local, regional and national level; the website and patient advocacy. She is also editor-in-chief of the peer-reviewed medicine journal Journal of Oncology Navigation and Survivorship and serves on the Leadership Council of the Academy of Oncology Nurse Navigators (AONN). A two-time breast cancer survivor, Lillie has worked tirelessly to improve the care of breast cancer patients around the world.
Lisa is a fitness expert, writer and a mom. With a passion and knowledge for fitness, combined with a degree in journalism, Lisa’s work has been published in national magazines such as Oxygen and Max Sports & Fitness, Muscle & Fitness Hers, Scottsdale Health and more. On TV, you may catch her hosting fitness DVD's or doing live segments on AZ Midday NBC-12.
Dr. Garnick is a clinical professor of medicine at Harvard Medical School and director of Cancer Network Services at Beth Israel Deaconess Medical Center, both in Boston. He also serves as editor-in-chief of Harvard Medical School’s annual report on prostate diseases. His specialties include internal medicine and medical oncology.
Michael Glode, MD, is a professor at Washington University in St. Louis in the Department of Medicine and Division of Medical Oncology.
Dr. Michael Crawford is a professor of medicine and the Lucie Stern chair in Cardiology at the University of California, San Francisco (UCSF), and chief of Clinical Cardiology at UCSF Medical Center. Dr. Crawford is the editor of 14 books and author of over 250 scientific articles in cardiology. His research interests include ischemic heart disease, valvular heart disease and the athlete’s heart.
Dr. Weisman is director of the Division of Rheumatology and professor of Medicine at Cedars-Sinai Medical Center in Los Angeles. His academic and research interests involve the genetic risk, epidemiology, treatment and outcome of rheumatic diseases. He is also an investigator for National Institutes of Health-sponsored studies in lupus, osteoarthritis, ankylosing spondylitis and rheumatoid arthritis (RA). Dr. Weisman is a reviewer and editor for many journals in the field of rheumatology, including the New England Journal of Medicine, Arthritis and Rheumatism, Journal of Rheumatology, Annals of Rheumatic Diseases and more.
Dr. Schweitz is a rheumatologist at Good Samaritan Medical Center in West Palm Beach, FL, and president of the Coalition of State Rheumatology Organizations (CSRO). He specializes in arthritis, osteoporosis and rheumatoid arthritis and is board certified in internal medicine and rheumatology.
Pat Whitworth, MD, is a breast surgical oncologist and director at Nashville Breast Center and associate clinical professor at Vanderbilt University in Nashville. He is also chairman of the board of directors of the American Society of Breast Surgeons Foundation, and vice-chair of the Breast Organ Site Committee at the American College of Surgeons Oncology Group.
Dr. Levy is a clinical professor of medicine at the University of Arizona College of Medicine and practices at the Banner Specialty Clinic, both located in Phoenix. He’s board certified in internal medicine, endocrinology and metabolism and nuclear medicine. He also worked as the editor-in-chief of Diabetes Forecast and is currently editor of First Messenger and is on the editorial board of Endocrine Today and Clinical Endocrinology News. In addition, Dr. Levy has been awarded a mastership in the American College of Endocrinology and is a past president of the American College of Endocrinology.
Dr. Bushardt is a tenured professor at the Department of Physician Assistant Studies at Wake Forest University School of Medicine in Winston-Salem, NC. He’s also professor of internal medicine and family medicine at Wake Forest Baptist Medical Center and professor at the Veterans Administration Medical Center in Salisbury, NC. His areas of research and clinical expertise include polypharmacy, aging, drug safety and healthcare workforce development. He’s also editor-in-chief of the Journal of the American Academy of Physician Assistants.
Dr. Weiner is the associate director and program leader for clinical research for Tulane Cancer Center and the Louisiana Cancer Research Consortium, as well as an active cancer clinician, caring for patients at the Tulane Cancer Center Comprehensive Clinic. He is especially committed to health disparity research and education.